neurogenic thoracic outlet syndrome
Conditions
Interventions
Conventional treatment group:? : Oral muscle relaxant (eperisone) 50mg 3 times a day
?Oral microcirculatory improving drug (dibazole), 10mg each time, 3 times a day, neurotrophic drug (mecobalamine), 500ug each time, 3 times a day
? Oral COX-2 inhibitor (celecoxib) 200mg once a day
Observation group:On the basis of conventional treatment, ultrasound guided brachial plexus nerve water separation therapy was given
Sponsors
Shenzhen Qianhai Shekou Free Trade Zone Hospital
Eligibility
Sex/Gender
All
Age
20 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1) The main complaint is neck, shoulder, back and upper limb pain and discomfort, the course of the disease is at least 3 months, the symptoms are repeated, completely normal when they do not occur, and the pain is unbearable when they occur. There are many inducing factors, such as cold, fatigue, prolonged time or repeated posture, sudden overexertion of the upper arm, sudden change of the head position, etc., can induce the occurrence or aggravation of symptoms; (2) It can be accompanied by some other stubborn symptoms (leading to misdiagnosis), such as stubborn singultus, pain in the chest area, repeated tinnitus, seizure dizziness, head and pillow pain, mental symptoms, indicating the middle finger end paresthesia, no serious cardiovascular, respiratory system and liver and kidney diseases; (3) Resting pain: manifested as local swelling, pain and discomfort before rest or sleep, no relief position in each part (how to put the affected limb is uncomfortable), affecting sleep, or wake up at night, neck, shoulder and limb can not fall asleep due to unspeakable discomfort; Severe patients do not dare to lie flat, or the pain is aggravated when lying flat; (4) After cervical manual massage, the pain symptoms worsened; Exclude the pain caused by other diseases (neck myofasciitis, shoulder periarthritis, nerve root type cervical spondylosis) or according to cervical spondylosis, shoulder periarthritis and other repeated treatment, the effect is not good; (5) Signs: The patient has significant tenderness at the thoracic outlet (including the supraclavicular scalene triangle and/or at the subclavian pectoral minor tendon), which may be accompanied by radiating pain in the ipilateral shoulder and upper limb; (6) Willing to cooperate with researchers, clearly understand the purpose of this clinical study, and willing to sign informed consent
Exclusion criteria
Exclusion criteria: (1) Serious consciousness, motor, cognitive, emotional disorders, affecting the implementation or evaluation of this clinical study, unable to carry out active rehabilitation treatment; (2) hepatitis, active tuberculosis, local metal foreign bodies, pregnancy, glaucoma, bone tumors, skin infections or skin lesions at closed sites; (3) Previous history of anaesthetic drug allergy, hormone drug allergy, gastrointestinal bleeding, bleeding tendency; (4) Walking instability, consider cervical spondylotic myelopathy; (5) Patients who are abnormally worried about local injection therapy and are unwilling to sign informed consent for treatment
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Visual analogue pain (VAS) score; | — |
Secondary
| Measure | Time frame |
|---|---|
| Tanaka Yasuhisa Cervical spondylosis symptom scale 20 points; | — |
Countries
China
Contacts
Public ContactWang Jun
Shenzhen Qianhai Shekou Free Trade Zone Hospital
Outcome results
None listed